NASDAQ:BRKR

Bruker - BRKR Stock Forecast, Price & News

$54.36

+1.30 (+2.45%)

(As of 10/3/2022 12:00 AM ET)

Add

Compare

Today's Range: $53.04
▼
$55.09
50-Day Range: $48.91
▼
$69.04
52-Week Range: $48.42
▼
$87.22

Volume: 1.03 million shs
Average Volume: 774,290 shs
Market Capitalization: $8.05 billion

P/E Ratio: 30.03
Dividend Yield: 0.38%
Price Target: $78.75

Bruker MarketRank™ Forecast

Analyst Rating: Hold
2.25 Rating Score
Upside/Downside: 44.9% Upside
$78.75 Price Target
Short Interest: Healthy
2.65% of Float Sold Short
Dividend Strength: Weak
Based on Four Factors
Sustainability: -1.48
Upright™ Environmental Score
News Sentiment: 0.22
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 11.35%
From $2.29 to $2.55 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.79 out of 5 stars

Computer And Technology Sector

125th out of 650 stocks

Analytical Instruments Industry

6th out of 29 stocks

3.1

Analyst's Opinion

Consensus Rating
Bruker has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $78.75, Bruker has a forecasted upside of 44.9% from its current price of $54.36.
Amount of Analyst Coverage
Bruker has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.65% of the float of Bruker has been sold short.
Short Interest Ratio / Days to Cover
Bruker has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Bruker has recently increased by 28.78%, indicating that investor sentiment is decreasing significantly.

1.7

Dividend Strength

Dividend Yield
Bruker has a dividend yield of 0.38%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Bruker has only been increasing its dividend for 1 years.
Dividend Coverage
The dividend payout ratio of Bruker is 11.05%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Bruker will have a dividend payout ratio of 7.84% next year. This indicates that Bruker will be able to sustain or increase its dividend.

3.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Bruker has received a 49.23% net impact score from Upright. Bruker seems to create the most significant positive value in categories "Taxes", "Jobs", and "Creating knowledge". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Biological hazard detectors", "Nuclear radiation detectors", and "Material x-ray scanners" products. See details.
Environmental Sustainability
The Environmental Impact score for Bruker is -1.48.

1.8

News and Social Media Coverage

News Sentiment
Bruker has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Computer and Technology companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Bruker this week, compared to 5 articles on an average week.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Bruker insiders have not sold or bought any company stock.
Percentage Held by Insiders
27.60% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
69.64% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Bruker are expected to grow by 11.35% in the coming year, from $2.29 to $2.55 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Bruker is 30.03, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 119.44.
Price to Earnings Ratio vs. Sector
The P/E ratio of Bruker is 30.03, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 358.39.
Price to Earnings Growth Ratio
Bruker has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Bruker has a P/B Ratio of 7.60. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Bruker (NASDAQ:BRKR) Stock

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

October 1, 2022 | americanbankingnews.com

Short Interest in Bruker Co. (NASDAQ:BRKR) Rises By 28.8%

September 30, 2022 | nasdaq.com

Insiders at Bruker Corporation (NASDAQ:BRKR) recouped some losses this week after buying this year, still down US$8.2k - Nasdaq

September 28, 2022 | globenewswire.com

Global Spectrometry Market Report to 2031 - Players Include Thermo Fisher Scientific, Danaher, Agilent Technologies and Bruker - GlobeNewswire

September 27, 2022 | americanbankingnews.com

Q3 2022 EPS Estimates for Bruker Co. Decreased by Analyst (NASDAQ:BRKR)

September 23, 2022 | nasdaq.com

Bruker (BRKR) Gains From New Product Bookings Amid Competition - Nasdaq

September 23, 2022 | finance.yahoo.com

Bruker (BRKR) Gains From New Product Bookings Amid Competition

September 20, 2022 | finance.yahoo.com

Bruker (NASDAQ:BRKR) sheds 11% this week, as yearly returns fall more in line with earnings growth - Yahoo Finance

September 20, 2022 | finance.yahoo.com

Bruker (NASDAQ:BRKR) sheds 11% this week, as yearly returns fall more in line with earnings growth

September 14, 2022 | finance.yahoo.com

Global Protein Engineering Market (2022 to 2027) - Featuring Bio-Rad Laboratories, Bruker, Codexis and Creative Biolabs Among Others - Yahoo Finance

September 8, 2022 | nasdaq.com

Bruker (NASDAQ:BRKR) shareholders have earned a 13% CAGR over the last five years - Nasdaq

September 7, 2022 | nasdaq.com

Bruker (NASDAQ:BRKR) shareholders have earned a 13% CAGR over the last five years

September 6, 2022 | nasdaq.com

Bruker is Now Oversold (BRKR) - Nasdaq

September 3, 2022 | uk.finance.yahoo.com

Bruker Corporation (NASDAQ:BRKR) drops to US$8.3b and insiders who purchased earlier this year lose another US$2.3k - Yahoo Finance UK

September 3, 2022 | finance.yahoo.com

Why Is Bruker (BRKR) Down 11.3% Since Last Earnings Report? - Yahoo Finance

September 2, 2022 | nasdaq.com

Why Is Bruker (BRKR) Down 11.3% Since Last Earnings Report? - Nasdaq

September 2, 2022 | finance.yahoo.com

Why Is Bruker (BRKR) Down 11.3% Since Last Earnings Report?

September 2, 2022 | finance.yahoo.com

Bruker Corporation (NASDAQ:BRKR) drops to US$8.3b and insiders who purchased earlier this year lose another US$2.3k

August 30, 2022 | finance.yahoo.com

Bruker (BRKR) Debuts Innovations for Proteomics & Metabolomics

August 29, 2022 | businesswire.com

Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software - Business Wire

August 29, 2022 | finance.yahoo.com

Bruker Launches New nanoElute® 2 nano-LC For 4D-Proteomics, Advances Fluxomics Applications with MetaboScape® 2023 Software

August 24, 2022 | seekingalpha.com

Bruker Corporation: Upside Is Limited From Here

August 22, 2022 | businesswire.com

Bruker Introduces Enabling New Scientific Capabilities for Cell Biology and Pathobiology Research with High-Field NMR Innovations - Business Wire

August 20, 2022 | businesswire.com

Global Dermatology Devices Market Research Report to 2027 - Featuring 3Gen, Aesthetic Group and Bruker Among Others - ResearchAndMarkets.com - Business Wire

August 19, 2022 | finance.yahoo.com

Global Super-resolution Microscopes Market to 2028 - Featuring Carl Zeiss, Nikon, Olympus and Bruker Among Others - Yahoo Finance

August 18, 2022 | finance.yahoo.com

Is Now An Opportune Moment To Examine Bruker Corporation (NASDAQ:BRKR)?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Company Calendar

Last Earnings: 8/03/2022
Ex-Dividend for 9/16 Dividend: 8/31/2022
Dividend Payable: 9/16/2022
Today: 10/03/2022
Next Earnings (Estimated): 11/07/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Analytical instruments
Sub-Industry: Life Sciences Tools & Services
Sector: Computer and Technology
Current Symbol: NASDAQ:BRKR
CUSIP: 11679410
CIK: 1109354
Web: www.bruker.com
Phone: (978) 663-3660
Fax: 978-663-5585
Employees: 7,765
Year Founded: 1960

Price Target and Rating

Average Stock Price Forecast: $78.75
High Stock Price Forecast: $90.00
Low Stock Price Forecast: $60.00
Forecasted Upside/Downside: +44.9%
Consensus Rating: Hold
Rating Score (0-4): 2.25
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.81
Trailing P/E Ratio: 30.03
Forward P/E Ratio: 23.74
P/E Growth: 1.37
Net Income: $277.10 million
Net Margins: 11.06%
Pretax Margin: 15.83%
Return on Equity: 31.36%
Return on Assets: 9.58%

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 2.55
Quick Ratio: 1.62

Sales & Book Value

Annual Sales: $2.42 billion
Price / Sales: 3.33
Cash Flow: $2.77 per share
Price / Cash Flow: 19.63
Book Value: $7.15 per share
Price / Book: 7.60

Miscellaneous

Outstanding Shares: 148,138,000
Free Float: 107,252,000
Market Cap: $8.05 billion
Optionable: Optionable
Beta: 1.19

Social Links

Key Executives

Dr. Frank H. Laukien Ph.D. (Age 62)
Chairman, CEO & Pres
Comp: $2.44M

Mr. Gerald N. Herman (Age 64)
Exec. VP & CFO
Comp: $1.08M

Dr. Mark R. Munch Ph.D. (Age 60)
Corp. Exec. VP and Pres of Bruker Nano Group & Corp.
Comp: $1.54M

Mr. Juergen Srega (Age 67)
Pres of Bruker CALID Group & Bruker Daltonics Division
Comp: $960.8k

Dr. Falko Busse Ph.D. (Age 55)
Pres of Bruker BioSpin Group
Comp: $738.54k

Mr. Justin Joseph Ward
Sr. Director of Investor Relations & Corp. Devel.

Mr. J. Brent Alldredge J.D. (Age 47)
Gen. Counsel

Mr. Collin J. D'Silva (Age 65)
Pres of Chemical Analysis Division

Stacey Desrochers
Treasurer & Director of Investor Relations

Mr. Urban Faeh
Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BRKR Stock - Frequently Asked Questions

Should I buy or sell Bruker stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BRKR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRKR, but not buy additional shares or sell existing shares.
View BRKR analyst ratings or view top-rated stocks.
What is Bruker's stock price forecast for 2022?: 4 analysts have issued 12-month price objectives for Bruker's shares. Their BRKR share price forecasts range from $60.00 to $90.00. On average, they anticipate the company's share price to reach $78.75 in the next year. This suggests a possible upside of 44.9% from the stock's current price.
View analysts price targets for BRKR or view top-rated stocks among Wall Street analysts.
How have BRKR shares performed in 2022?: Bruker's stock was trading at $83.91 at the start of the year. Since then, BRKR stock has decreased by 35.2% and is now trading at $54.36.
View the best growth stocks for 2022 here.
When is Bruker's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, November 7th 2022.
View our BRKR earnings forecast.
How were Bruker's earnings last quarter?: Bruker Co. (NASDAQ:BRKR) posted its earnings results on Wednesday, August, 3rd. The medical research company reported $0.45 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.45. The medical research company earned $588.40 million during the quarter, compared to analyst estimates of $590.94 million. Bruker had a net margin of 11.06% and a trailing twelve-month return on equity of 31.36%. During the same quarter in the previous year, the firm posted $0.44 EPS.
How often does Bruker pay dividends? What is the dividend yield for Bruker?: Bruker announced a quarterly dividend on Friday, August 12th. Investors of record on Thursday, September 1st will be given a dividend of $0.05 per share on Friday, September 16th. This represents a $0.20 annualized dividend and a yield of 0.37%. The ex-dividend date of this dividend is Wednesday, August 31st.
Read our dividend analysis for BRKR.
Is Bruker a good dividend stock?: Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.38%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 11.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.84% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.
What guidance has Bruker issued on next quarter's earnings?: Bruker updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of $2.29-$2.33 for the period, compared to the consensus estimate of $2.29. The company issued revenue guidance of $2.48 billion-$2.53 billion, compared to the consensus revenue estimate of $2.55 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?: 126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.
What other stocks do shareholders of Bruker own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).
What is Bruker's stock symbol?: Bruker trades on the NASDAQ under the ticker symbol "BRKR."
How do I buy shares of Bruker?: Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bruker's stock price today?: One share of BRKR stock can currently be purchased for approximately $54.36.
How much money does Bruker make?: Bruker (NASDAQ:BRKR) has a market capitalization of $8.05 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.81 on an earnings per share basis.
How many employees does Bruker have?: The company employs 7,765 workers across the globe.
Does Bruker have any subsidiaries?: The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK Instruments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
How can I contact Bruker?: Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.

This page (NASDAQ:BRKR) was last updated on 10/3/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bruker - BRKR Stock Forecast, Price & News

Bruker MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month